Skip to main content
TipRanks
Go Ultimate75% OFF

Arbutus Biopharma (ABUS) Q1 2020 Earnings Report

1,288 Followers

ABUS Q1 2020 EPS Results

Actual EPS
-$0.25
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.47

ABUS Q1 2020 Revenue Results

Actual Revenue
$1.49M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+119.59%

Earnings Announcement Details

Quarter
Q1 2020
Date
05/11/2020
Time
Before Open
Conference Call
Monday, May 11, 2020
ABUS Upcoming Earnings

Arbutus Biopharma's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q1 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

ABUS Earnings History

ABUS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.02--0.01――
Nov 10, 20262026 (Q3)-0.020.30-0.04850.00% (+0.34)
Aug 12, 20262026 (Q2)-0.02-0.030.01-400.00% (-0.04)
May 13, 20262026 (Q1)-0.030.87-0.13769.23% (+1.00)
Mar 23, 20262025 (Q4)-0.04-0.01-0.0785.71% (+0.06)
Nov 13, 20252025 (Q3)-0.03-0.04-0.160.00% (+0.06)
Aug 06, 20252025 (Q2)-0.050.01-0.11109.09% (+0.12)
May 14, 20252025 (Q1)-0.10-0.13-0.1-30.00% (-0.03)
Mar 27, 20252024 (Q4)-0.08-0.07-0.1241.67% (+0.05)
Nov 06, 20242024 (Q3)-0.09-0.10-0.1216.67% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed